THC Therapeutics, Inc. (THCT)

THC Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is August - July.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Apr 30, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021	Jul 31, 2020	Jul 31, 2019
Net Income	-0.56	-0.39	-1.52	-1.89	-1.93	-23.31
Depreciation & Amortization	0	0	0.01	0.02	0.02	0.03
Other Amortization	-	-	0.01	0.28	0.43	-
Asset Writedown & Restructuring Costs	-	-	-	-	-	2.43
Stock-Based Compensation	0.22	0.09	0.84	0.12	0.44	23.82
Other Operating Activities	-0.09	-0.19	-0.33	0.57	0.03	-3.53
Change in Inventory	-	0	0	-0	-	-
Change in Accounts Payable	0.24	0.36	0.6	0.42	0.29	0.23
Change in Other Net Operating Assets	0	0.04	-0.04	0.1	0.14	-
Operating Cash Flow	-0.18	-0.09	-0.42	-0.39	-0.59	-0.33
Capital Expenditures	-	-	-	-	-	-0
Other Investing Activities	-	-	-	-0.15	-	-
Investing Cash Flow	-	-	-	-0.15	-	-0
Short-Term Debt Issued	-	0.04	0.13	0.09	0.58	0.89
Total Debt Issued	0.09	0.04	0.13	0.09	0.58	0.89
Short-Term Debt Repaid	-	-0.05	-0.05	-0.1	-0.27	-0.24
Total Debt Repaid	-0	-0.05	-0.05	-0.1	-0.27	-0.24
Net Debt Issued (Repaid)	0.09	-0.01	0.07	-0.01	0.31	0.65
Issuance of Common Stock	-	0.1	0.15	0.51	-	-
Repurchase of Common Stock	-	-	-0.1	-	-	-
Financing Cash Flow	0.18	0.09	0.12	0.79	0.31	0.65
Net Cash Flow	0	-0	-0.3	0.25	-0.27	0.31
Free Cash Flow	-0.18	-0.09	-0.42	-0.39	-0.59	-0.33
Free Cash Flow Per Share	-0.01	-0.00	-0.01	-0.02	-0.04	-0.03
Levered Free Cash Flow	-0.03	-0.07	-0.05	0.16	0.18	9.1
Unlevered Free Cash Flow	0.02	-0.02	-0.01	0.22	0.06	9.29
Change in Net Working Capital	-0.16	-0.2	-0.24	-0.68	-0.47	-0.6

Source: S&P Global Market Intelligence. Standard template. Financial Sources.